UNIVERSITY OF SARGODHA
🇵🇰Pakistan
Clinical Trials
3
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)The Effect of Vitamin D3 Therapy in Post Menopausal Women and Assessment of Changes in Bone Mineral Density After Orally Vitamin D3 Administration
Phase 1
- Conditions
- Vitamin D Deficiency
- Interventions
- Drug: Oral administration of vitamin D3Drug: Vitamin D3 50000 UNT Oral CapsuleDietary Supplement: milk, Dietary and life style modifications.
- First Posted Date
- 2022-05-25
- Last Posted Date
- 2022-05-25
- Lead Sponsor
- University of Sargodha
- Target Recruit Count
- 80
- Registration Number
- NCT05389943
- Locations
- 🇵🇰
Arsalan Khalid, Faisalābad, Punjab, Pakistan
Monitoring the IgG/IgM Antibodies in COVID-19 Patients
Completed
- Conditions
- COVID-19 Infections
- First Posted Date
- 2021-03-22
- Last Posted Date
- 2022-07-21
- Lead Sponsor
- University of Sargodha
- Target Recruit Count
- 373
- Registration Number
- NCT04810117
- Locations
- 🇵🇰
University of Sargodha, Sub campus Bhakkar, Bhakkar, Punjab, Pakistan
🇵🇰University of Sargodha, Sargodha, Punjab, Pakistan
Montelukast - a Treatment Choice for COVID-19
Completed
- Conditions
- Covid19SARS-CoV-2 Infection
- Interventions
- First Posted Date
- 2021-01-19
- Last Posted Date
- 2021-01-19
- Lead Sponsor
- University of Sargodha
- Target Recruit Count
- 150
- Registration Number
- NCT04714515
- Locations
- 🇨🇳
Department of Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China, Shanghai, China
🇵🇰Shaukat Khanum Memorial Cancer Hospital & Research Centre, Johar Town, Lahore, Pakistan, Lahore, Punjab, Pakistan
News
No news found